When the transaction referred to the fifth paragraph of Note 14 of the notes to the financial statements has been consummated, we will be in a position to render the following consent.
/s/ KPMG LLP
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Satsuma Pharmaceuticals, Inc.:
We consent to the use of our report dated June 21, 2019, except as to the fifth paragraph of Note 14, which is as of September , 2019, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
[unsigned]
San Diego, California
, 2019
